2023
DOI: 10.1016/j.cmpb.2022.107244
|View full text |Cite
|
Sign up to set email alerts
|

In silico thrombectomy trials for acute ischemic stroke

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 37 publications
0
5
0
Order By: Relevance
“…This work proposed the use of the SSM approach for the generation of virtual populations of cerebrovascular anatomies, useful for the development of in silico trials for AIS treatments. In [8], the first proof-of-concept in silico stroke trial was implemented, based on a surrogate model of the thrombectomy procedure trained on a dataset of 94 high-fidelity thrombectomy simulations run in patient-specific vascular models. The methodology described in the present work would enable the creation of the desired number of virtual stroke patients for increasing the reliability of an in silico stroke trial.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…This work proposed the use of the SSM approach for the generation of virtual populations of cerebrovascular anatomies, useful for the development of in silico trials for AIS treatments. In [8], the first proof-of-concept in silico stroke trial was implemented, based on a surrogate model of the thrombectomy procedure trained on a dataset of 94 high-fidelity thrombectomy simulations run in patient-specific vascular models. The methodology described in the present work would enable the creation of the desired number of virtual stroke patients for increasing the reliability of an in silico stroke trial.…”
Section: Discussionmentioning
confidence: 99%
“…High-fidelity in silico models of the thrombectomy procedure have been recently proposed in the literature [4][5][6][7]. The stent-retriever thrombectomy simulation developed in [4], used to replicate a patient-specific case, was integrated into a framework for running the first proof-of-concept in silico trial for stroke treatments [8]. The framework was validated by replicating a real clinical trial and then employed to compare treatment outcomes in different subpopulations and with different thrombectomy devices, demonstrating the potentiality of the in silico approach to support clinical stroke trials.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Mechanical properties of the thrombus are defined following experimental characterization of clots produced in vitro . Because of their high accuracy, these models are being used as fundamental building blocks for the development of in silico clinical trials ( 23 ). Recently, the authors included both a clot fragmentation model and external aspiration ( 24 ).…”
Section: Introductionmentioning
confidence: 99%